Published • loading... • Updated
Allogene Therapeutics (NASDAQ:ALLO) SVP Sells 29,697 Shares of Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Allogene Therapeutics (NASDAQ:ALLO) SVP Sells 29,697 Shares of Stock
Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) SVP Earl Martin Douglas sold 29,697 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $2.12, for a total value of $62,957.64. Following the transaction, the senior vice president directly owned 488,267 shares in the company, valued at $1,035,126.04. This trade represents a 5.73% decrease in their position. The transaction w…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
